Loading...
Market
What will be Septerna Inc.'s stock price by March 31, 2025?
2
Resolution / Starting Odds
Above $25 • 25%
$20-$25 • 25%
$15-$20 • 25%
Below $15 • 25%
Nasdaq stock price data
Story
Goldman Sachs-backed Septerna Inc. Raises $288 Million in IPO, Valuation Reaches $970 Million After 31% Surge on Nasdaq Debut
Oct 25, 2024, 01:39 PM
Septerna Inc., a Goldman Sachs-backed biotechnology company, has successfully completed its upsized initial public offering (IPO), raising $288 million. The company offered 16 million shares at a price of $18 each, an increase from the previously proposed 15.27 million shares. Following its debut on the Nasdaq, Septerna's shares surged nearly 31%, leading to a market valuation of approximately $970 million. The IPO reflects positive investor sentiment in the biotech sector, particularly for companies focused on G protein-coupled receptors (GPCRs), which are crucial for developing new therapies. The funds raised will support Septerna's pipeline of GPCR drugs, addressing unmet patient needs.
View original story
Similar markets
Above $10 • 25%
$8-$10 • 25%
$6-$8 • 25%
Below $6 • 25%
Less than $20 • 25%
$20 to $30 • 25%
$30 to $40 • 25%
More than $40 • 25%
Above $25 • 25%
$20 - $25 • 25%
$15 - $20 • 25%
Below $15 • 25%
Above $10 • 25%
$5 - $10 • 25%
$1 - $5 • 25%
Below $1 • 25%
Stock price above $50 • 25%
Stock price between $20 and $50 • 25%
Stock price between $5 and $20 • 25%
Stock price below $5 • 25%
Below $150 • 25%
$150 - $175 • 25%
$175 - $200 • 25%
Above $200 • 25%
Above $10 • 25%
$8 to $10 • 25%
$6 to $8 • 25%
Below $6 • 25%
Above $200 • 25%
Between $150 and $200 • 25%
Between $100 and $150 • 25%
Below $100 • 25%
Below $300 • 25%
$300 to $350 • 25%
$350 to $400 • 25%
Above $400 • 25%
Increase by over 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by over 10% • 25%